Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.95 $1,709 - $2,925
-1,500 Reduced 75.0%
500 $0
Q1 2023

May 15, 2023

SELL
$1.2 - $2.19 $524,760 - $957,687
-437,300 Reduced 99.54%
2,000 $2,000
Q4 2022

Feb 14, 2023

SELL
$1.63 - $3.52 $237,979 - $513,920
-146,000 Reduced 24.94%
439,300 $742,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $208,269 - $1.07 Million
285,300 Added 95.1%
585,300 $1.83 Million
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $660,000 - $1.26 Million
300,000 New
300,000 $714,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $489M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.